Holen Sie sich die Stockscreener-App
2.095
0.71%
-0.015
Schlusskurs vom Vortag:
$2.11
Offen:
$2.08
24-Stunden-Volumen:
43,287
Relative Volume:
0.53
Marktkapitalisierung:
$3.76M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-4.14M
KGV:
-0.2889
EPS:
-7.2511
Netto-Cashflow:
$-4.79M
1W Leistung:
+19.03%
1M Leistung:
+21.80%
6M Leistung:
-62.32%
1J Leistung:
-71.84%
1-Tages-Spanne:
$1.9246
$2.11
1-Wochen-Bereich:
$1.7009
$2.16
52-Wochen-Spanne:
$1.30
$7.74
Bone Biologics Corp Stock (BBLG) Company Profile
Firmenname
Bone Biologics Corp
Sektor
Branche
Telefon
(781) 552-4452
Adresse
2 BURLINGTON WOODS DRIVE,, BURLINGTON
Vergleichen Sie BBLG mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BBLG
Bone Biologics Corp
|
2.095 | 3.79M | 0 | -4.14M | -4.79M | -7.2511 |
|
ABT
Abbott Laboratories
|
122.55 | 210.84B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
92.70 | 137.17B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
353.80 | 133.55B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
100.77 | 127.71B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
83.92 | 48.33B | 5.88B | 1.34B | 799.60M | 2.3489 |
Bone Biologics Corp Aktie (BBLG) Neueste Nachrichten
Bone Biologics Corp (BBLG) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Keensight Capital Acquires Majority Stake in Isto Biologics, a Leading Orthobiologics Player, from Thompson Street Capital Partners - Daytona Beach News-Journal
Why Bone Biologics Corporation Equity Warrant stock is rated strong buyQuarterly Performance Summary & Reliable Price Breakout Signals - Newser
Bone Biologics (BBLG) Stock Analysis Report | Financials & Insights - Benzinga
Orthobiologics Market | Global Market Analysis Report2035 - Fact.MR
Book value per share of Bone Biologics Corp Warrant 2023-2027 on Bone Biologics – NASDAQ:BBLGW - TradingView
EBIT per share of Bone Biologics Corp Warrant 2023-2027 on Bone Biologics – NASDAQ:BBLGW - TradingView
Revenue per share of Bone Biologics Corp Warrant 2023-2027 on Bone Biologics – NASDAQ:BBLGW - TradingView
Net current asset value per share of Bone Biologics Corp Warrant 2023-2027 on Bone Biologics – NASDAQ:BBLGW - TradingView
Can Bone Biologics Corporation Equity Warrant stock surprise with earnings upsideWeekly Investment Report & Growth Focused Stock Reports - newser.com
Zacks Small Cap Raises Earnings Estimates for Bone Biologics - Defense World
Will Bone Biologics Corporation Equity Warrant stock attract ESG investors2025 Market Outlook & Risk Managed Investment Strategies - newser.com
Measuring Bone Biologics Corporation Equity Warrant’s beta against major indices2025 Risk Factors & Daily Stock Trend Watchlist - newser.com
Will earnings trigger a reversal in Bone Biologics CorporationWeekly Profit Analysis & Free Weekly Chart Analysis and Trade Guides - newser.com
Is Bone Biologics Corporation stock attractive for growth ETFsJuly 2025 Chart Watch & High Accuracy Investment Entry Signals - newser.com
Orthobiologics Market Poised to Hit $9.39 Billion by 2029 with Accelerating Growth Trends - openPR.com
Bone Biologics Corporation Equity Warrant stock prediction for this weekMarket Performance Recap & Advanced Technical Signal Analysis - newser.com
Can KNSL stock reach $100 price target2025 Earnings Impact & Weekly High Potential Stock Alerts - newser.com
Is Bone Biologics Corporation stock supported by strong cash flows2025 Price Action Summary & Weekly Consistent Profit Watchlists - newser.com
Will PHAXIAM Therapeutics S.A. (2E40) stock enhance shareholder valueEarnings Performance Report & Daily Oversold Stock Bounce Ideas - newser.com
Is CMTL a good long term investmentPrice Support Zones & Daily Tips From Top Market Analysts - earlytimes.in
Bone Biologics Corporation Stock Analysis and ForecastDividend Aristocrats List & Free Realize Exceptional Returns - earlytimes.in
What’s the recovery path for long term holders of Bone Biologics Corporation2025 Pullback Review & Free Weekly Chart Analysis and Trade Guides - newser.com
Will Bone Biologics Corporation stock maintain growth story2025 Price Momentum & Risk Adjusted Buy and Sell Alerts - Fundação Cultural do Pará
[10-Q] Bone Biologics Corp Quarterly Earnings Report | BBLG SEC FilingForm 10-Q - Stock Titan
Will Bone Biologics Corporation Equity Warrant stock gain from strong economyWeekly Trade Analysis & Safe Swing Trade Setups - newser.com
Will Bone Biologics Corporation stock sustain high P E ratiosEarnings Performance Report & Weekly High Return Stock Opportunities - newser.com
Is it too late to sell Bone Biologics Corporation Equity WarrantQuarterly Trade Report & Risk Adjusted Buy/Sell Alerts - newser.com
Will Bone Biologics Corporation stock maintain dividend yield2025 Market Trends & Fast Entry High Yield Stock Tips - newser.com
Finanzdaten der Bone Biologics Corp-Aktie (BBLG)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.34%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):